Zorevenersen, an experimental drug for severe form of epilepsy, Dravet syndrome, reduced seizures by up to 91% in children aged between two and 18 years old. The corresponding study was published in ...

Taking aim at the leading risk factor for cancer, The Mark Foundation for Cancer Research and the Samuel Waxman Cancer Research Foundation (SWCRF) today announced $2.5 million to support science at ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

Testing Market size is USD 2.24 Billion in 2025 and is expected to reach USD 6.66 Billion by 2035 due to the increasing adoption of NIPTAustin, March 10, 2026 (GLOBE NEWSWIRE) -- According to SNS ...

A new study led by researchers at Adelaide University and published in Science Advances reveals why some cancers can grow and survive in the body, while others cannot. It turns out that intense ...

Scientists have reported a laboratory culture system that can regenerate hair follicles in vitro with functional features normally seen only in living tissue, including follicle downgrowth, hair ...